ANDHealth, Australia’s leading digital health commercialisation organisation, today announced a partnership with the global Digital Therapeutics Alliance to accelerate understanding, adoption and integration of clinically validated digital therapeutics (DTx) in Australia.

MEDIA RELEASE

ANDHealth, Australia’s leading digital health commercialisation organisation, today announced a partnership with the global Digital Therapeutics Alliance to accelerate understanding, adoption and integration of clinically validated digital therapeutics (DTx) in Australia.

The Digital Therapeutics Alliance (DTA) is the leading global trade association of industry leaders and stakeholders engaged in the advancement of evidence-driven digital therapeutics. As the sole international organisation on digital therapeutic thought leadership and education, the Digital Therapeutics Alliance provides patients, clinicians, payors, and policymakers with the necessary tools to evaluate and utilise DTx products.

The ANDHealth-DTA collaboration will provide a focal point for the understanding of the value of DTx in an Australian healthcare setting and will provide ANZ specific input into the DTA’s global activities.

Bronwyn Le Grice, Founder & CEO of ANDHealth commented, “Digital therapeutics are one of the most exciting areas of healthcare innovation today and we are seeing increasing numbers of high potential growth companies in this space in Australia, however the broader environment is still not ready for wholesale adoption of these cutting-edge products.”

“By working with the Digital Therapeutics Alliance we are able to bring international best practice to Australia on how these high impact technologies can be deployed into our healthcare system for the benefit of all Australians.”

Megan Coder, Executive Director of the Digital Therapeutics Alliance remarked, “Digital therapeutics are rapidly transforming the way patients can access and realise significant improvements in their health via products which prevent, manage and alleviate disease and disability through technology.”

“The Digital Therapeutics Alliance is delighted to partner with ANDHealth to facilitate an increased understanding of this new and emerging space within Australia and to share best practices and industry learnings globally.”

Within the collaborative framework, ANDHealth and the Digital Therapeutics Alliance will provide mutual expert content and resources to advance policy, regulation, reimbursement and other key changes necessary to see digital therapeutics as an ongoing element of healthcare systems around the world.

‍

ABOUT DIGITAL THERAPEUTICS

Digital therapeutics (DTx) deliver evidence-based therapeutic interventions that are driven by high quality software programs to prevent, manage, or treat a medical disorder or disease. They are used independently or in concert with medications, devices, or other therapies to optimize patient care and health outcomes.

DTx products incorporate advanced technology best practices relating to design, clinical evaluation, usability, and data security. They are reviewed and cleared or certified by regulatory bodies as required to support product claims regarding risk, efficacy, and intended use.

Digital therapeutics empower patients, clinicians, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions.

ABOUT ANDHEALTH

ANDHealth was formed to address an identified gap in the Australian Innovation landscape: to provide programs and support to digital health companies that was specific to the challenges of commercialising in this new and emerging sector. By forming a multi-sectoral, multidisciplinary membership and working collaboratively across Australia, we bring proven expertise to our innovators and investors.

ANDHealth is Australia’s only organisation specialised in the acceleration of commercialisation in digital health technologies and has a proven track record of accelerating the global scale-up of high growth potential companies creating jobs, advanced manufacturing, clinical trials, and patient impact. Our unique, non-profit, industry-led model helps Australian digital health companies to navigate the pathway to institutional investment and international market entry.

ANDHealth is also Australia’s only female-founded and female-led health technology accelerator.

ABOUT DIGITAL THERAPEUTICS ALLIANCE

Founded in 2017, the Digital Therapeutics Alliance is a non-profit trade association of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics. As the leading international organization on digital therapeutic thought leadership and education, the Digital Therapeutics Alliance provides patients, clinicians, payors, and policymakers with the necessary tools to evaluate and utilize DTx products.

‍